Pylera is a new triple fixed-dose combination capsule containing bismuth, metronidazole and tetracycline. In combination with omeprazole, it is indicated for the eradication of H. pylori and prevention of relapse of peptic ulcers in patients with active or a history of H. pylori associated ulcers. The aim of this report is to evaluate the efficacy, safety and potential place in therapy of Pylera.
The Medicines in Practice bulletin for Pylera can be accessed here